221 related articles for article (PubMed ID: 4047087)
1. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
Reddy MV; Irvin TR; Randerath K
Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
[TBL] [Abstract][Full Text] [Related]
2. Accurate and sensitive quantitation of N7-methyldeoxyguanosine-3'-monophosphate by 32P-postlabeling and storage-phosphor imaging.
Haque K; Cooper DP; van Delft JH; Lee SM; Povey AC
Chem Res Toxicol; 1997 Jun; 10(6):660-6. PubMed ID: 9208172
[TBL] [Abstract][Full Text] [Related]
3. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
Gupta RC
Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
[TBL] [Abstract][Full Text] [Related]
4. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
6. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
7. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
Otteneder M; Eder E; Lutz WK
Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
[TBL] [Abstract][Full Text] [Related]
8. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
[TBL] [Abstract][Full Text] [Related]
9. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
[TBL] [Abstract][Full Text] [Related]
10. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
Randerath K; Randerath E; Agrawal HP; Reddy MV
IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
[TBL] [Abstract][Full Text] [Related]
11. Development of methods for measuring biological markers of formaldehyde exposure.
Fennell TR
Res Rep Health Eff Inst; 1994 Jun; (67):1-20; discussion 21-6. PubMed ID: 7917119
[TBL] [Abstract][Full Text] [Related]
12. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
Reddy MV; Randerath K
Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
14. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
Reddy MV
IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
[TBL] [Abstract][Full Text] [Related]
15. Development of a 32P-postlabeling method for the detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo.
Schuler D; Budiawan B; Eder E
Chem Res Toxicol; 1999 Apr; 12(4):335-40. PubMed ID: 10207122
[TBL] [Abstract][Full Text] [Related]
16. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin.
Essigmann JM; Donahue PR; Story DL; Wogan GN; Brunengraber H
Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740
[No Abstract] [Full Text] [Related]
17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
18. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
[TBL] [Abstract][Full Text] [Related]
19. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
20. Monitoring carcinogen actions on DNA by 32P-postlabeling.
Randerath K; Randerath E
Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
